BetterLife Pharma Inc.
BETR
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.01M | -3.59M | -3.31M | -2.15M | -1.65M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 3.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.38M | 1.51M | 1.46M | 74.80K | -752.30K |
| Change in Net Operating Assets | -28.90K | 241.70K | 387.20K | 241.90K | 652.20K |
| Cash from Operations | -1.66M | -1.84M | -1.46M | -1.83M | -1.75M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.52M | 1.52M | 1.52M | 300.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 739.40K | 1.13M | 707.40K | 2.30M | 2.41M |
| Repurchase of Common Stock | -100.00K | -100.00K | -100.00K | -100.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.20K | 20.20K | 20.20K | -- | 0.00 |
| Cash from Financing | 1.61M | 1.89M | 1.59M | 1.85M | 1.78M |
| Foreign Exchange rate Adjustments | -100.00 | 0.00 | 0.00 | 0.00 | 2.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.20K | 49.90K | 126.70K | 19.20K | 35.40K |
